Matthew Blake Mcrae - 28 Nov 2025 Form 4 Insider Report for Arlo Technologies, Inc. (ARLO)

Signature
/s/ Brian Busse, Attorney-in-Fact
Issuer symbol
ARLO
Transactions as of
28 Nov 2025
Transactions value $
-$3,672,876
Form type
4
Date filed
01 Dec 2025, 18:18
Previous filing
05 Nov 2025
Next filing
09 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCRAE MATTHEW BLAKE CEO, Director 5770 FLEET STREET, CARLSBAD /s/ Brian Busse, Attorney-in-Fact 2025-12-01 0001654733

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARLO Common Stock Gift $0 -563K -31.97% $0.00 1.2M 28 Nov 2025 Direct F1
transaction ARLO Common Stock Sale -$3.67M -257K -21.46% $14.28 942K 01 Dec 2025 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction represents a charitable gift of 563,293 shares of common stock to a donor advised fund.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
F3 The weighted average sale price for the transaction reported was $14.2779, and the range of prices were between $14.06 and $14.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.